Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5362_Библиотеки_им_академика_М_И_Перельмана.pdf
Graphene Quantum Dots-based Nanomaterials for Drug Delivery 375
Fig.12.7. M To load the chemotherapeutic medication doxorubicin (Dox) onto sEVs. D-CysGQDs. a A schematic shows how D-Cys-GQDs make loading with Dox easier for sEVs. b Reducing
efficiency and fluorescent spectra (max = 360 nm) were used to characterize the direct addition
of Dox (200 M) onto the D-Cys-GQDs (7.5–22). Using a confocal microscope at room temperature, c a comparison is made between the loading methods of D-Cys-GQDs (15 M) and ultrasound
treatment for Dox (200 M for both tactics). d Chiral GQDs improve the efficiency with which Dox
is loaded into sEVs. Scale bars, 10 m e Confocal images showing in vitro 3T3 cell uptake of free
Dox and sEVs-Dox (loaded ratio 15 M/200 M, D-Cys-GQDs/Dox) and f viability of cell measured
using the CCK-8 test. Reproduced with permission from the American Chemical Society [58]
cell viability of all samples. (Fig. 12.7f) was equivalent to sEVs-Dox (HepG2: 44.2
9.2% and HeLa: 27.4 6.5% cell proliferation inhibition) [58].
9 Toxicology Concern of GQDs-Based Nanomaterials
for Drug Delivery
Because of the risk of accumulation and biological targeting with other particles
that alter the properties of the infused nanoparticles and interfere with cell activity,
using quantum dots as a therapeutic agent is not yet practical. GQDs synthesized
using various approaches, geometrical parameters, and surface groups should be
376 M. Emamul Kabir et al.
tested for their biodistribution, organ accumulation, and genotoxicity. Nanofabrication techniques and surface features such as surface charges, nanosizes, functional groups, contaminants, and element doping can contribute to GQD toxicity
[58, 76, 77]. Previous research has shown that the poisonousness of GQDs relies
on concentration; nonetheless, cells may endure very curt concentrations of GQDs,
making their use in biomedical applications unrealistic. For instance, if the inten-
−1
sity of GQD is enhanced from 50 g/mL
mg/mL, cell viability is cut in half [78].
GQDs’ concentration-dependent ROS production increases their toxicity. The toxicity of GQDs stems from their size rather than their concentration. The toxicity of
GQDs varies with their size and form. For both in vivo/vitro cytotoxicity, GQDs were
shown to have a maximum side edge size of 50 nm [79]. Setting the quantitative cytotoxicity barrier for GQDs is extremely difficult because their toxicity changes over
time [80]. A-GQDs (200 g/mL) can generate DNA breaking via H-attachment and
stacking [81], while N-GQDs can buckle the configuration of lipid droplets, disorder
the redox-sensitive technique, disturb calcium homeostasis, and cause ferroptosis.
The promise of GQDs in medication delivery has led to much research into their
toxicity in biological systems. Researchers administered numerous doses to model
clinical drug testing to further understand the effects of PEG-modified GQDs in vivo
[82]. No clear evidence of GQDs-PEG toxicity was found. Cancer drugs like Dox and
Docetaxel bypass the cell membrane and cause cytotoxicity by restricting replication
and translation, preventing DNA and RNA synthesis [38]. These medicines break
DNA by intercalating between two base pairs. They become radicals inside cells and
can cleave DNA. Because of their non-specificity and systemic noxiousness, these
medicines have limited drug solubility and severe side effects. The nano-drug carrier
bypasses internalization mechanisms that resist anti-cancer drugs to reach the nuclei.
They kill tumor cells by entering the cell and traveling to the nucleus via clathrinmediated, caveolae-mediated endocytosis, or receptor-mediated. GQD-DOX conjugation enhances cytotoxicity by targeting drug transport and DNA cleavage [46].
Table 12.3 summerized the toxicity behavior of different GQDs-based nanomaterials.
10 Challenges and Future Perspectives
GQDs have been acquired to deliver drug vehicles in nanomedicine studies efficiently.
Their physicochemical and biochemical properties guarantee this. Despite years of
study, GQDs are only just becoming mainstream in therapeutic applications. Due to
concerns over in vivo toxicity and long-term biodegradability, carbon-based nanomaterials like GQDs are limited to studying cells and small animals in the lab. Due to
these concerns, the use of quantum dots in nano DDS-based pharmaceuticals has been
halted [37]. Toxicities and a lack of contradicting data have prevented GQDs from
being widely used as pharmaceutical delivery vehicles. GQD, a recently discovered
nanomaterial, has limitless applications in medication administration. GQDs that
extend therapeutic windows and efficiently transfer medications to the target site
with minimal systemic toxicity should be the primary focus of development rather
Graphene Quantum Dots-based Nanomaterials for Drug Delivery 377
Table 12.3 Toxicity of different GQDs-based nanomaterials. Adapted and reproduced with
permission form ACS [15]
Materials Cells Assay Concentration
GQDs-PEG A549, HeLa WST-1, LDH 160, 640 24 > 95,
fGQDs HFF MTT 40, 200 24 >8,>30[83]
GQDs A549 MTT 100 24 80 [11]
GQDs MGC-803,
MCF-7
mGQDs C6, A549, MTT 200 24 >80 [85]
N-GQDs HeLa CCK-8 400 24 >80 [86]
cGQDs KB,A549 MDCK,
MDA-MB231
GQDs HeLa CCK-8 200 24 80 [88]
mGQDs HeLa,
MCF-10A,MCF-7
HGQDs HUVEC CCK-8 500 48 >80 [90]
mGQDs HeLa MTT 8000 24 ∼50 [78]
MTT 400 24 ∼70 [84]
MTT, LDH 500 21d/24 >95 [87]
MTT 2000 24 ∼97 [89]
(μg/mL)
Incubation
time (h)
Cell
viability
%
∼85
Reference
[82]
than their synthesis, problems, and expensive separation. In addition, a Microfluidic
environment should be properly attributed in laboratory settings to mimic the biological process in drug delivery experiments to flow effectively and pressure control
[91–93] in microchannel as more shear stress may threaten cell viability. Besides,
this nano-drug delivery method must advance locally and systemically across various
cell types and tissue categories. The target site-GQD interaction might be studied in
greater depth with the help of improved molecular-levelunderlying forces study using
models to appreciate small-scale difficulties [47]. Since GQDs can traverse biological
barriers like the Blood–Brain Obstacle despite their diminutive size, they have been
introduced to nano-neurology. However, more research is required to address toxicity concerns. Inflammation is mitigated using GQDs to restrain immune cells. When
treating autoimmune diseases, such as inflammatory bowel disease [94], GQDs can
be a viable option.
Drug delivery is enhanced because of its malleable core, tailored architecture,
and bonding (π-stacking), making it superior to other Nano-DDS. Due to their great
biocompatibility and minimal systemic toxicity, GQD-based drug delivery methods
may become more practical in the future. Gene delivery and therapy can benefit
from viral vectors because they convey genetic material to their intended recipients.
Immunogenicity problems with viral vectors are resolved with GQDs, allowing them
to be used in clinical settings. They are excellent candidates for traceable transfection
vectors to transfer genes in-vitro/vivo because of their tiny size, capacity to bypass
living barriers, extraordinary constancy, and luminescence GQDs can load nucleic
378 M. Emamul Kabir et al.
acid (RNA, DNA) and act as a non-viral gene vector by conjugating motioning
molecules and cationic polymers in the basal surface. The GQD-DDS has a functionalized component that safeguards drug transport in the mouth from acidic environments [95]. GQDs will soon dominate pharmaceutical, biomedical, and related
industries as they are studied and documented in depth.
11 Conclusions
GQDs-based DDS increase drug loading, targeting, and efficacy in targeted cancer
therapy. Nanoshells, liposomes, dendrimers, superparamagnetic, nucleic acid-based
nanoparticles and CNTs, target physiologically active fractions into living systems.
Next-generation GQDs have biological potential. These materials can carry medications well. GQDs can multimodally conjugate like graphene and GO, making
them potential cancer cell therapy and surveillance carriers. Their structure boosts
chemotherapeutic efficacy. Nanostructured materials having active units can be
synthesized using several methods. Synthesis mode can modify GQD functions based
on output. GQD energy bandgaps affect electroluminescence, photoluminescence,
and absorption.
GQD knowledge gaps must be filled to use these novel nanomaterials. Recent
research has revealed the promise of these nanocarriers in drug delivery applications.
However, they still have limitations in targeted cancer therapy. GQD’s research for
drug delivery applications are still incubating. Therefore, many nanomaterial functions are unknown. GQDs model drugs permeating the lipid membrane in nanoseconds with minimal cell membrane deformation. These findings support GQD-based
drug delivery system molecular design and application. GQDs can deliver genes,
peptides, and non-anticancer drugs to specific locations. Despite GQDs’ enhanced
biocompatibility, animal models are needed to examine their long-term toxicity and
mechanisms of immunological, reproductive, and neurological system effects. Characterization standards are essential since GQDs’ physicochemical characteristics
vary by manufacture. Systematic studies are needed since GQD size impacts toxicity, surface functionalization, and biological carrier crossing. GQD research may
improve biological efficacy and address GQD-based drug delivery system design
and manufacturing difficulties.
Conflict of Interest Statement The authors have declared no conflict of interest.
References
1. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an
emerging platform for cancer therapy. Nat Nanotechnol 2(12):751–760
Graphene Quantum Dots-based Nanomaterials for Drug Delivery 379
2. Du J-Z, Du X-J, Mao C-Q, Wang J (2011) Tailor-made dual pH-sensitive polymer-doxorubicin
nanoparticles for efficient anticancer drug delivery. J Am Chem Soc 133(44):17560–17563
3. Zeng Z (2011) Recent advances of chitosan nanoparticles as drug carriers. Int J of Nanomed
765
4. Lu Y, Low PS (2002) Folate-mediated delivery of macromolecular anticancer therapeutic
agents. Adv Drug Deliv Rev 54(5):675–693
5. Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy.
Adv Drug Deliv Rev 56(11):1649–1659
6. Zu (2010) Preparation, characterization, and in vitro targeted delivery of folate-decorated
paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomed 669
7. Shen J, Zhu Y, Yang X, Li C (2012) Graphene quantum dots: emergent nanolights for
bioimaging, sensors, catalysis and photovoltaic devices. Chem Commun 48(31):3686
8. Dong J, Wang K, Sun L, Sun B, Yang M, Chen H, Wang Y, Sun J, Dong L (2018) Application
of graphene quantum dots for simultaneous fluorescence imaging and tumor-targeted drug
delivery. Sens Actuators B Chem 256:616–623
9. Hui L, Huang J, Chen G, Zhu Y, Yang L (2016) Antibacterial property of graphene quantum
dots (Both source material and bacterial shape matter). ACS Appl Mat Inter 8(1):20–25
10. Joshi PN, Kundu S, Sanghi SK, Sarkar D (2016) Graphene quantum dots - from emergence to
nanotheranostic applications, in: smart drug Delivery System, InTech
11. Sui X, Luo C, Wang C, Zhang F, Zhang J, Guo S (2016) Graphene quantum dots enhance
anticancer activity of cisplatin via increasing its cellular and nuclear uptake. Nanomed: Nanotec
Bio Med 12(7):1997–2006
12. Sweetman MJ, Hickey SM, Brooks DA, Hayball JD, Plush SE (2019) A practical guide to
prepare and synthetically modify graphene quantum dots. Adv Func Mat 29(14):1808740
13. Bokare A, Chinnusamy S, Erogbogbo F (2021) TiO2-graphene quantum dots nanocomposites
for photocatalysis in energy and biomedical applications. Catalyst 11(3):319
14. Zhu S, Song Y, Zhao X, Shao J, Zhang J, Yang B (2015) The photoluminescence mechanism
in carbon dots (graphene quantum dots, carbon nanodots, and polymer dots): current state and
future perspective. Nano Res 8(2):355–381
15. Biswas MC, Islam MT, Nandy PK, Hossain MM (2021) Graphene quantum dots (GQDs) for
bioimaging and drug delivery applications: a review. ACS Mat Lett 3(6):889–911
16. Zhu S, Zhang J, Qiao C, Tang S, Li Y, Yuan W, Li B, Tian L, Liu F, Hu R, Gao H, Wei H,
Zhang H, Sun H, Yang B (2011) Strongly green-photoluminescent graphene quantum dots for
bioimaging applications. Chem Commun 47(24):6858
17. Tian R, Zhong S, Wu J, Jiang W, Shen Y, Jiang W, Wang T (2016) Solvothermal method to
prepare graphene quantum dots by hydrogen peroxide. Opt Mater 60:204–208
18. Abbas A, Rubab S, Rehman A, Irfan S, Sharif HMA, Liang Q, Tabish TA (2023) One-step
green synthesis of biomass-derived graphene quantum dots as a highly selective optical sensing
probe. Mater Today Chem 30:101555
19. Tang L, Ji R, Cao X, Lin J, Jiang H, Li X, Teng KS, Luk CM, Zeng S, Hao J, Lau SP (2012)
Deep ultraviolet photoluminescence of water-soluble self-passivated graphene quantum dots.
ACS Nano 6(6):5102–5110
20. Dong Y, Shao J, Chen C, Li H, Wang R, Chi Y, Lin X, Chen G (2012) Blue luminescent
graphene quantum dots and graphene oxide prepared by tuning the carbonization degree of
citric acid. Carbon 50(12):4738–4743
21. Li Y, Zhao Y, Cheng H, Hu Y, Shi G, Dai L, Qu L (2012) Nitrogen-doped graphene quantum
dots with oxygen-rich functional groups. J Am Chem Soc 134(1):15–18
22. Luo Z, Qi G, Chen K, Zou M, YuwenL, Zhang X, Huang W, Wang L (2016) Microwave-assisted
preparation of white fluorescent graphene quantum dots as a novel phosphor for enhanced
white-light-emitting diodes. Adv Func Mater 26(16):2739–2744
23. Pan D, Zhang J, Li Z, Wu M (2010) Hydrothermal route for cutting graphene sheets into
blue-luminescent graphene quantum dots. Adv Mater 22(6):734–738
24. Chua CK, Sofer Z, Šimek P, Jankovský O, Klímová K, Bakardjieva S, Hrdličková Kučková Š,
Pumera M (2015) Synthesis of strongly fluorescent graphene quantum dots by cage-opening
buckminsterfullerene. ACS Nano 9(3):2548–2555
380 M. Emamul Kabir et al.
25. Hai X, Feng J, Chen X, Wang J (2018) Tuning the optical properties of graphene quantum dots
for biosensing and bioimaging. J Mater Chem B 6(20):3219–3234
26. Sk MA, Ananthanarayanan A, Huang L, Lim KH, Chen P (2014) Revealing the tunable
photoluminescence properties of graphene quantum dots. J Mater Chem C 2:6954–6960
27. Nazeeruddin MK, Di Censo D, Humphry-Baker R, Grätzel M (2006) Highly selective and
reversible optical, colorimetric, and electrochemical detection of mercury (II) by amphiphilic
ruthenium complexes anchored onto mesoporous oxide films. Adv Func Mater 16(2):189–194
28. Zhu S, Zhang J, Tang S, Qiao C, Wang L, Wang H, Liu X, Li B, Li Y, Yu W, Wang X, Sun
H, Yang B (2012) Surface chemistry routes to modulate the photoluminescence of graphene
quantum dots: from fluorescence mechanism to up-conversion bioimaging applications. Adv
Func Mater 2(22):4732–4740
29. Suryawanshi R, Kurrey R, Sahu S, Ghosh KK (2023) Facile and scalable synthesis of undoped, doped and co-doped graphene quantum dots: a comparative study on their impact for
environmental applications. RSC Adv 13(1):701–719
30. George D, Suri A, Dutta K, Nayak S (2022) Targeted drug delivery using graphene quantum
dots: approaches. Limitations and Future Perspectives. ECS Trans 107(1):16081–16098
31. Li Z, Fan J, Tong C, Zhou H, Wang W, Li B, Liu B, Wang W (2019) A smart drug-delivery
nanosystem based on carboxylated graphene quantum dots for tumor-targeted chemotherapy.
Nanomed 14(15):2011–2025
32. Rakhshaei R, Namazi H, Hamishehkar H, Rahimi M (2020) Graphene quantum dot crosslinked carboxymethyl cellulose nanocomposite hydrogel for pH-sensitive oral anticancer drug
delivery with potential bioimaging properties. Int J Biol Micromol 150:1121–1129
33. Moasses Ghafary S, Rahimjazi E, Hamzehil H, Modarres Mousavi SM, Nikkhah M,
Hosseinkhani S (2022) Design and preparation of a theranostic peptideticle for targeted
cancer therapy: Peptide-based codelivery of doxorubicin/curcumin and graphene quantum dots,
Nanomed. Nanotech Biol Med 42, 102544
34. Cai X, Luo Y, Zhang W, Du D, Lin Y (2016) PH-sensitive ZnO quantum dots-doxorubicin
nanoparticles for lung cancer targeted drug delivery. ACS Appl Mater Interface 8(34):22442–
22450
35. Mari E, Mardente S, Morgante E, Tafani M, Lococo E, Fico F, Valentini F, Zicari A (2016)
Graphene oxide nanoribbons induce autophagic vacuoles in neuroblastoma cell lines. Int J Mol
Sci 17(12):1995
36. Dwitya SS, Hsueh Y-H, Wang SS-S, Lin K-S (2023) Ultrafine nitrogen-doped graphene
quantum dot structure and antibacterial activities against bacillus subtilis 3610. Mater Chem
Phy 295:127135
37. Jampilek J, Kralova K (2021) Advances in drug delivery nanosystems using graphene-based
materials and carbon nanotubes. Mater 14(5):1059
38. Liang J, Huang Q, Hua C, Hu J, Chen B, Wan J, Hu Z, Wang B (2019) PH-Responsive
nanoparticles loaded with graphene quantum dots and doxorubicin for intracellular imaging,
drug delivery and efficient cancer therapy. ChemistrySelect 4(20):6004–6012
39. Zhu Y-J, Chen F (2015) PH-responsive drug-delivery systems. Chem Asian J 10(2):284–305
40. Choi SYC, Collins CC, Gout PW, Wang Y (2013) Cancer-generated lactic acid: a regulatory,
immunosuppressive metabolite? J Pathol 230(4):350–355
41. Liu J, Qiu R, Zhang J, Li Y, Sang W, Tang P, Rivera Gil P (2015) Fluorescent graphene quantum
dots as traceable, pH-sensitive drug delivery systems. Int J Nanomed 6709
42. Seyyedi Zadeh E, Ghanbari N, Salehi Z, Derakhti S, Amoabediny G, Akbari M, Asadi
Tokmedash M (2023) Smart pH-responsive magnetic graphene quantum dots nanocarriers
for anticancer drug delivery of curcumin. Mater Chem Phy 297, 127336
43. Soleymani J, Hasanzadeh M, Somi MH, Ozkan SA, Jouyban A (2018) Targeting and sensing
of some cancer cells using folate bioreceptor functionalized nitrogen-doped graphene quantum
dots. Int J Biol Micromol 118:1021–1034
44. Behzadi S, Serpooshan V, Tao W, Hamaly MA, Alkawareek MY, Dreaden EC, Brown D,
Alkilany AM, Farokhzad OC, Mahmoudi M (2017) Cellular uptake of nanoparticles: journey
inside the cell. Chem Soc Rev 46(14):4218–4244
Graphene Quantum Dots-based Nanomaterials for Drug Delivery 381
45. Kydd J, Jadia R, Velpurisiva P, Gad A, Paliwal S, Rai P (2017) Targeting strategies for the
combination treatment of cancer using drug delivery systems. Pharm 9(4):46
46. Wang C, Wu C, Zhou X, Han T, Xin X, Wu J, Zhang J, Guo S (2013) Enhancing cell nucleus
accumulation and dna cleavage activity of anti-cancer drug via graphene quantum dots. Sci
Rep 3(1):2852
47. Xue Z, Sun Q, Zhang L, Kang Z, Liang L, Wang Q, Shen J-W (2019) Graphene quantum dot
assisted translocation of drugs into a cell membrane. Nanoscale 11(10):4503–4514
48. Thakur M, Mewada A, Pandey S, Bhori M, Singh K, Sharon M, Sharon M (2016) Milk-derived
multi-fluorescent graphene quantum dot-based cancer theranostic system. Mater Sci Eng: C
67:468–477
49. Khodadadei F, Safarian S, Ghanbari N (2017) Methotrexate-loaded nitrogen-doped graphene
quantum dots nanocarriers as an efficient anticancer drug delivery system. Mater Sci Eng : C
79:280–285
50. Huang C-L, Huang C-C, Mai F-D, Yen C-L, Tzing S-H, Hsieh H-T, Ling Y-C, C hang J-Y
(2015) Application of paramagnetic graphene quantum dots as a platform for simultaneous
dual-modality bioimaging and tumor-targeted drug delivery. J Mater Chem B 3(4):651–664
51. Wang X, Sun X, Lao J, He H, Cheng T, Wang M, Wang S, Huang F (2014) Multifunctional
graphene quantum dots for simultaneous targeted cellular imaging and drug delivery. Colloids
Sur B: Biointerface 122:638–644
52. Iannazzo D, Pistone A, Salamò M, Galvagno S, Romeo R, Giofré SV, Branca C, Visalli G,
Di Pietro A (2017) Graphene quantum dots for cancer targeted drug delivery. Int J Pharm
518(1–2):185–192
53. Wang Z, Xia J, Zhou C, Via B, Xia Y, Zhang F, Li Y, Xia L, Tang J (2013) Synthesis of strongly
green-photoluminescent graphene quantum dots for drug carrier. Colloids Sur B: Biointerface
112:192–196
54. Ju J, Regmi S, Fu A, Lim S, Liu Q (2019) Graphene quantum dot based charge-reversal nanomaterial for nucleus-targeted drug delivery and efficiency controllable photodynamic therapy.
J Biol 12(6)
55. Chen P, Yue H, Zhai X, Huang Z, Ma GH, Wei W, Yan LT (2019) Transport of a graphene
nanosheet sandwiched inside cell membranes. Sci Adv 5(6)
56. Suzuki N, Wang Y, Elvati P, Qu Z-B, Kim K, Jiang S, Baumeister E, Lee J, Yeom B, Bahng JH,
Lee J, Violi A, Kotov NA (2016) Chiral graphene quantum dots. ACS Nano 10(2):1744–1755
57. Liu C, Elvati P, Majumder S, Wang Y, Liu AP, Violi A (2019) Predicting the time of entry of
nanoparticles in lipid membranes. ACS Nano 13(9):10221–10232
58. Zhang Y, Kim G, Zhu Y, Wang C, Zhu R, Lu X, Chang HC, Wang Y (2023) Chiral graphene
quantum dots enhanced drug loading into small extracellular vesicles, ACS Nan. 10
59. Yeom J, Guimaraes PPG, Ahn HM, Jung B, Hu Q, McHugh K, Mitchell MJ, Yun C,
Langer R, Jaklenec A (2020) Chiral supraparticles for controllable nanomedicine. Adv Mater
32(1):1903878
60. Baimanov D, Wang J, Zhang J, Liu K, Cong Y, Shi X, Zhang X, Li Y, Li X, Qiao R, Zhao
Y, Zhou Y, Wang L, Chen C (2022) In situ analysis of nanoparticle soft corona and dynamic
evolution. Nat Commun 13(1):5389
61. Chen F, Gao W, Qiu X, Zhang H, Liu L, Liao P, Fu W, Luo Y (2017) Graphene quantum
dots in biomedical applications: recent advances and future challenges. Front Laboratry Med
1(4):192–199
62. Tian P, TangL, Teng KS, Lau SP (2018) Graphene quantum dots from chemistry to applications.
Mater Today Chem 10:221–258
63. Razmi H, Mohammad-Rezaei R (2013) Graphene quantum dots as a new substrate for immobilization and direct electrochemistry of glucose oxidase: application to sensitive glucose
determination. Biosens Bioelectron 41:498–504
64. Ahmadi-Kashani M, Dehghani H, Zarrabi A (2020) A biocompatible nanoplatform formed
by MgAl-layered double hydroxide modified Mn3O4/N-graphene quantum dot conjugatedpolyaniline for pH-triggered release of doxorubicin. Mater Sci Eng: C 114, 111055
382 M. Emamul Kabir et al.
65. Skotland T, Sandvig K, Llorente A (2017) Lipids in exosomes: current knowledge and the way
forward. Prog Lipid Res 66:30–41
66. Abels ER, Breakefield XO (2016) Introduction to extracellular vesicles: biogenesis, rna cargo
selection, content, release, and uptake. Cell Mol Neurobiol 36(3):301–312
67. Choi BG, Yang MH, Park TJ, Huh YS, Lee SY, Hong WH, Park H (2011) Programmable
peptide-directed two-dimensional arrays of various nanoparticles on graphene sheets.
Nanoscale 3(8):3208
68. Peng J, Gao W, Gupta BK, Liu Z, Romero-Aburto R, Ge L, Song L, Alemany LB, Zhan X,
Gao G, Vithayathil SA, Kaipparettu BA, Marti AA, Hayashi T, Zhu J-J, Ajayan PM (2012)
Graphene quantum dots derived from carbon fibers. Nano Lett 12(2):844–849
69. Fuhrmann G, Serio A, Mazo M, Nair R, Stevens MM (2015) Active loading into extracellular
vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J
Control Release 205:35–44
70. Pomatto MAC, Bussolati B, D’Antico S, Ghiotto S, Tetta C, Brizzi MF, Camussi G (2019)
Improved loading of plasma-derived extracellular vesicles to encapsulate Antitumor miRNAs.
Mol Ther Methods Clin Dev 13:133–144
71. Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, Patel T, Piroyan A, Sokolsky
M, Kabanov AV, Batrakova EV (2015) Exosomes as drug delivery vehicles for Parkinson’s
disease therapy. J Control Release 207:18–30
72. Noor-Ul-Ain M, Eriksson S, Schmidt M, Asghar P-C, Lin P, Holtz M, Syväjärvi G (2016)
Yazdi, Tuning the emission energy of chemically doped graphene quantum dots. Nanomater
6(11):198
73. Jin SH, Kim DH, Jun GH, Hong SH, Jeon S (2013) Tuning the photoluminescence of graphene
quantum dots through the charge transfer effect of functional groups. ACS Nano 7(2):1239–
1245
74. Schindler C, Collinson A, Matthews C, Pointon A, Jenkinson L, Minter RR, Vaughan TJ, Tigue
NJ (2019) Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro
potency. PLoS ONE 14(3):e0214545
75. Teng Y, Yuan S, Shi J, Pong PWT (2022) A multifunctional nanoplatform based on graphene
quantum dots-cobalt ferrite for monitoring of drug delivery and fluorescence/magnetic
resonance bimodal cellular imaging. Adv NanoBiomed Res 2(10):2200044
76. Ou L, Song B, Liang H, Liu J, Feng X, Deng B, Sun T, Shao L (2016) Toxicity of graphenefamily nanoparticles: a general review of the origins and mechanisms. Part Fibre Toxicol
13(1):57
77. Wang S, Cole IS, Li Q (2016) The toxicity of graphene quantum dots. RSC Adv 6(92):89867–
89878
78. Chandra A, Deshpande S, Shinde DB, Pillai VK, Singh N (2014) Mitigating the cytotoxicity
of graphene quantum dots and enhancing their applications in bioimaging and drug delivery.
ACS Macro Lett 3(10):1064–1068
79. Wang D, Zhu L, Chen J-F, Dai L (2015) Can graphene quantum dots cause DNA damage in
cells? Nanoscale 7(21):9894–9901
80. Liang L, Kong Z, Kang Z, Wang H, Zhang L, Shen J-W (2016) Theoretical evaluation on
potential cytotoxicity of graphene quantum dots. ACS Biomater Sci Eng 2(11):1983–1991
81. Xu L, Dai Y, Wang Z, Zhao J, Li F, White JC, Xing B (2018) Graphene quantum dots in alveolar
macrophage: uptake-exocytosis, accumulation in nuclei, nuclear responses and DNA cleavage.
Part Fiber Toxicol 15(1):45
82. Iannazzo D, Ziccarelli I, Pistone A (2017) Graphene quantum dots: multifunctional nanoplatforms for anticancer therapy. J Mater Chem B 5(32):6471–6489
83. Mehrdad-Vahdati B, Pourhashem S, Sedghi M, Vaezi Z, Shojaedin-Givi B, Rashidi A, NaderiManesh H (2019) A novel aspect of functionalized graphene quantum dots in cytotoxicity
studies. Toxicol Vittro 61:104649
84. Wu C, Wang C, Han T, Zhou X, Guo S, Zhang J (2013) Insight into the cellular internalization
and cytotoxicity of graphene quantum dots. Adv Health Mater 2(12):1613–1619
Graphene Quantum Dots-based Nanomaterials for Drug Delivery 383
85. Yuan X, Liu Z, Guo Z, Ji Y, Jin M, Wang X (2014) Cellular distribution and cytotoxicity of
graphene quantum dots with different functional groups. Nanoscale Res Lett 9(1):108
86. Liu Q, Guo B, Rao Z, Zhang B, Gong JR (2013) Strong two-photon-induced fluorescence from
photostable, biocompatible nitrogen-doped graphene quantum dots for cellular and deep-tissue
imaging. Nano Lett 13(6):2436–2441
87. Nurunnabi M, Khatun Z, Huh KM, Park SY, Lee DY, Cho KJ, Lee Y (2013) In vivo biodistribution and toxicology of carboxylated graphene quantum dots. ACS Nano 7(8):6858–6867
88. Jiang D, Chen Y, Li N, Li W, Wang Z, Zhu J, Zhang H, Liu B, Xu S (2015) Synthesis of
luminescent graphene quantum dots with high quantum yield and their toxicity study. PLoS
ONE 10(12):e0144906
89. Some S, Gwon A-R, Hwang E, Bahn G, Yoon Y, Kim Y, Kim S-H, Bak S, Yang J, Jo D-G,
Lee H (2014) Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives.
Sci Rep 4(1):6314
90. Yan C, Hu X, Guan P, Hou T, Chen P, Wan D, Zhang X, Wang J, Wang C (2020) Highly
biocompatible graphene quantum dots: green synthesis, toxicity comparison and fluorescence
imaging. J Mater Sci 55(3):1198–1215
91. Kabir ME, Kim S (2023) Method to fabricate round cross-sectional channel using thermal
expansion of air for passive flow regulators. Electrophor 44(21–22):1698–1703
92. Oh KW, Lee K, Ahn B, Furlani EP (2012) Design of pressure-driven microfluidic networks
using electric circuit analogy. Lab Chip 12(3):515–545
93. Lee K, Kim C, Young Yang J, Lee H, Ahn B, Xu L, Yoon Kang J, Oh KW (2012) Gravityoriented microfluidic device for uniform and massive cell spheroid formation. Biomicrofluidics
6(1)
94. Lee BC, Lee JY, Kim J, Yoo J.M, Kang I, Kim JJ, Shin N, Kim DJ, Choi SW, Kim D, Hong
BH,. Kang KS (2020) Graphene quantum dots as anti-inflammatory therapy for colitis. Sci
Adv 6(18)
95. Zhao C, Song X, Liu Y, Fu Y, Ye L, Wang N, Wang F, Li L, Mohammad niaei M, Zhang
M, Zhang Q, Liu J (2020) Synthesis of graphene quantum dots and their applications in drug
delivery. J Nanobiotechnol 18(1):142
